Breast implant-associated anaplastic large-cell lymphoma

Area of Science:

• Oncology
• Surgical Pathology
• Immunology

Background:

• Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare T-cell lymphoma.
• Diagnosis often relies on identifying neoplastic cells in seroma fluid.
• Preoperative diagnosis is crucial for appropriate surgical planning and patient management.

Purpose of the Study:

• To evaluate the suitability of cytologic examination of fine-needle aspirate (FNA) specimens from peri-implant seroma for diagnosing BIA-ALCL.
• To assess the role of ancillary techniques like flow cytometry and immunohistochemistry in preoperative diagnosis.

Main Methods:

• Fine-needle aspiration of peri-implant seroma fluid.
• Cytologic evaluation of FNA smears.
• Flow cytometric immunophenotyping of collected cells.
• Immunohistochemistry staining of cell samples.

Main Results:

• Cytologic evaluation of peri-implant seroma aspirates, combined with flow cytometry and immunohistochemistry, is effective.
• These methods provide a suitable preoperative diagnostic approach for suspected BIA-ALCL.
• This diagnostic strategy facilitates planning for surgical intervention.

Conclusions:

• Preoperative diagnosis of BIA-ALCL can be reliably achieved through cytologic assessment of seroma fluid.
• The integration of flow cytometry and immunohistochemistry enhances diagnostic accuracy.
• This approach supports informed surgical management decisions in patients with suspected BIA-ALCL.